Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Trauner

Showing results (431-440 of 776) with videos related to

Pageof 78
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|January 4, 2020
Non-invasive diagnosis of cirrhosis and long-term disease monitoring by transient elastography in patients with Wilson diseaseRafael Paternostro, Jan Pfeiffenberger, Peter Ferenci, et al.
Journal of Gastroenterology|December 11, 2021
Distinct prognostic value of different portal hypertension-associated features in patients with primary biliary cholangitisLukas Burghart, Emina Halilbasic, Philipp Schwabl, et al.
Journal of Gastroenterology and Hepatology|May 8, 2019
Impact of farnesoid X receptor single nucleotide polymorphisms on hepatic decompensation and mortality in cirrhotic patients with portal hypertensionGeorg Semmler, Benedikt Simbrunner, Bernhard Scheiner, et al.
Wiener Klinische Wochenschrift|July 27, 2017
Non-invasive liver fibrosis assessment and HCV treatment initiation within a systematic screening program in HIV/HCV coinfected patientsDavid Chromy, Philipp Schwabl, Theresa Bucsics, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 1, 2026
Summative Comorbidities Are Independently Associated With Mortality in Patients With Hepatocellular CarcinomaTobias Meischl, Moritz Steurer, Lorenz Balcar, et al.
Radiology|May 19, 2015
Morphologic and Molecular Features of Hepatocellular Adenoma with Gadoxetic Acid-enhanced MR ImagingAhmed Ba-Ssalamah, Célia Antunes, Diana Feier, et al.
Atherosclerosis|September 29, 2009
Low-dose atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis after one year of treatmentTatjana Stojakovic, Thierry Claudel, Csilla Putz-Bankuti, et al.
Scientific Reports|January 18, 2023
The systemic and hepatic alternative renin-angiotensin system is activated in liver cirrhosis, linked to endothelial dysfunction and inflammationLukas Hartl, Benedikt Rumpf, Oliver Domenig, et al.
Journal of Hepatology|October 19, 2020
Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortalityDalila Costa, Benedikt Simbrunner, Mathias Jachs, et al.
Plos One|November 5, 2014
Proton pump inhibitor intake neither predisposes to spontaneous bacterial peritonitis or other infections nor increases mortality in patients with cirrhosis and ascitesMattias Mandorfer, Simona Bota, Philipp Schwabl, et al.
Pageof 78

Showing results (431-440 of 776) with videos related to

Sort By:
Pageof 78
Liver International : Official Journal of the International Association for the Study of the Liver|January 4, 2020
Non-invasive diagnosis of cirrhosis and long-term disease monitoring by transient elastography in patients with Wilson diseaseRafael Paternostro, Jan Pfeiffenberger, Peter Ferenci, et al.
Journal of Gastroenterology|December 11, 2021
Distinct prognostic value of different portal hypertension-associated features in patients with primary biliary cholangitisLukas Burghart, Emina Halilbasic, Philipp Schwabl, et al.
Journal of Gastroenterology and Hepatology|May 8, 2019
Impact of farnesoid X receptor single nucleotide polymorphisms on hepatic decompensation and mortality in cirrhotic patients with portal hypertensionGeorg Semmler, Benedikt Simbrunner, Bernhard Scheiner, et al.
Wiener Klinische Wochenschrift|July 27, 2017
Non-invasive liver fibrosis assessment and HCV treatment initiation within a systematic screening program in HIV/HCV coinfected patientsDavid Chromy, Philipp Schwabl, Theresa Bucsics, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 1, 2026
Summative Comorbidities Are Independently Associated With Mortality in Patients With Hepatocellular CarcinomaTobias Meischl, Moritz Steurer, Lorenz Balcar, et al.
Radiology|May 19, 2015
Morphologic and Molecular Features of Hepatocellular Adenoma with Gadoxetic Acid-enhanced MR ImagingAhmed Ba-Ssalamah, Célia Antunes, Diana Feier, et al.
Atherosclerosis|September 29, 2009
Low-dose atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis after one year of treatmentTatjana Stojakovic, Thierry Claudel, Csilla Putz-Bankuti, et al.
Scientific Reports|January 18, 2023
The systemic and hepatic alternative renin-angiotensin system is activated in liver cirrhosis, linked to endothelial dysfunction and inflammationLukas Hartl, Benedikt Rumpf, Oliver Domenig, et al.
Journal of Hepatology|October 19, 2020
Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortalityDalila Costa, Benedikt Simbrunner, Mathias Jachs, et al.
Plos One|November 5, 2014
Proton pump inhibitor intake neither predisposes to spontaneous bacterial peritonitis or other infections nor increases mortality in patients with cirrhosis and ascitesMattias Mandorfer, Simona Bota, Philipp Schwabl, et al.
Pageof 78